Life and Health Insurance

Aegon NV

Aegon NV released FY2025 9 Months Earnings on February 19, 2026 (EST) with actual revenue of USD 7.495 B and EPS of USD 0.4024

Aegon NV released FY2025 Q3 earnings on February 19 (EST), actual revenue USD 3.249 B, actual EPS USD 0.1365

Aegon NV released FY2025 earnings on February 19 Pre-Market EST, actual revenue USD 14.05 B (forecast USD 11.65 B), actual EPS USD 0.6817 (forecast USD 1.0201)

Aegon NV released FY2025 Q4 earnings on February 19 Pre-Market (EST), actual revenue USD 3.253 B, actual EPS USD 0.1367

Aegon NV to Release FY2025 Annual Earnings on February 19, 2026 Pre-Market EST, Forecast Revenue USD 11.73 B, EPS USD 1.0201

Morgan Stanley Analyst Maintains Buy Rating on Aegon NV

Dutch Global Insurance Group Plans to Relocate Headquarters to the US and Rebrand

Aegon NV to Release FY2025 Q3 Earnings on November 22, 2025 (EST)

Aegon NV released FY2025 Semi-Annual Earnings on August 21, 2025 (EST) with actual revenue of USD 7.495 B and EPS of USD 0.4024

Aegon NV released FY2025 Q1 earnings on August 21 (EST), actual revenue USD 3.601 B, actual EPS USD 0.1933

Aegon NV released FY2025 Q2 earnings on August 21 (EST), actual revenue USD 3.894 B, actual EPS USD 0.209

Aegon NV to Release FY2025 Q2 Earnings on August 21, 2025 (EST)

Berenberg Maintains Buy Rating on Aegon

Aegon Completes 150 Million Euro Share Repurchase

Wereldhave N.V. Secures 50 Million Euro Loan from Global Life Netherlands

Netherlands Global AIM Increases UL Solutions Holding

Aegon Plans to Repurchase Stocks

DOJ Investigates Live Nation and AEGON's Collusion in Refund During Pandemic

Aegon NV to Release FY2025 Q1 Earnings on May 22, 2025, Pre-Market EST

Exane Raises AEGON's Rating to Outperform

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

Ordinary dividend (cash)

Ex Date: 2026.06.15 (EST), Cash dividend 0.2468 USD

Aegon has priced USD 500 million in senior unsecured notes with a 5.625% coupon, maturing on May 7, 2036, to refinance subordinated debt. The issuance will settle on May 7, 2026, and aims to repurchase certain unregistered subordinated notes while also funding general corporate purposes. The notes will be listed on the NYSE to enhance liquidity and visibility for investors. Aegon’s capital management strategy focuses on replacing subordinated debt with senior funding, improving funding flexibility and optimizing its liability profile. Spark rates AEG stock as Neutral, citing attractive valuation but volatile performance.

Tip Ranks

Aegon Ltd.

Aegon Funding Corp II Pref Share AEFC 5.1 12/15/49

Aegon Prices USD 500 Million Senior Notes to Refinance Subordinated Debt

AEGOF

AEFC

Aegon has published the agenda for its Annual General Meeting (AGM) scheduled for June 10, 2026. The meeting will present the 2025 Annual Accounts and propose a final dividend of EUR 0.21 per common share, totaling EUR 0.40 for 2025. Proposals include extending Lard Friese's term as CEO until 2030 and appointing Leni Boeren to the Board. Corien Wortmann is not eligible for re-election, and Karen Fawcett will not stand for re-election. Shareholders can participate virtually and vote in advance. More details are available on Aegon's AGM webpage.

Fidelity

Aegon publishes agenda for 2026 Annual General Meeting

Aegon Ltd. has initiated a cash tender offer for five series of subordinated notes, including euro, U.S. dollar, and Dutch guilder-denominated securities. The offer, which runs until May 7, 2026, aims to manage Aegon's liability structure and financial leverage, providing investors an exit from legacy instruments. The purchase prices range from 75% to 89.625% of principal. Spark's analysis rates AEG stock as Neutral, citing attractive valuation but moderated by volatile financial performance. Aegon is a major player in global financial services, focusing on investment and retirement solutions.

Aegon Launches Tender Offer to Buy Back Five Series of Subordinated Notes

Aegon has proposed the sale of its U.K. insurance and pensions arm to Standard Life for GBP 750 million in cash and a 15.3% equity stake. The deal, expected to close by the end of 2026 pending regulatory approvals, will classify Aegon UK as held for sale and report results as discontinued operations from H1 2026. Aegon filed pro forma accounts illustrating the potential financial impact of the sale. Spark's analysis rates AEG stock as Neutral, citing attractive valuation but moderated by volatile performance.

Aegon Files Pro Forma Accounts for Proposed Sale of U.K. Insurance and Pensions Arm to Standard Life

In a report released on April 24, from Berenberg Bank maintained a Buy rating on Aegon NV, with a price target of €8.07. The company’s shares closed last Friday at €6.87.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on Aegon NV is a Moderate Buy with an average price target of €7.53.

Berenberg Bank Keeps Their Buy Rating on Aegon NV (0Q0Y)

EQNR

European stock markets were mostly lower on Wednesday, with the Stoxx Europe down 0.4% and the FTSE 100 down 0.5%. GSK completed a $950 million acquisition of 35Pharma, but its shares fell 2.3%. Stellantis is considering a partnership with Dongfeng Motor, with shares up 2.1%. Aegon agreed to sell Aegon UK to Standard Life for £2 billion, with shares down 0.2%. Equinor's Danske Commodities cut 28 positions, leading to a 2.3% drop in shares.

fidelity

GlaxoSmithKline plc

Equinor Asa

European Stocks Track Mostly Lower in Wednesday Trading

PHNX

Standard Life's CEO Andy Briggs has expressed concerns about retirement adequacy while announcing a £2bn acquisition of Aegon UK, which will create the second largest retail pensions platform in the UK. The deal aims to enhance retirement standards for consumers and expand Standard Life's customer base. Briggs indicated potential for further mergers and acquisitions, emphasizing the importance of investing in customer outcomes amidst a competitive market. The acquisition is expected to boost annual profits by £160m and generate £400m in excess cash.

cityam

Phoenix Group Holdings plc

Standard Life’s Briggs warns ‘retirement adequacy is a genuine concern’, as £2bn Aegon deal unveiled

Aegon NV(AEG.US)